Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs)
Last Updated: Wednesday, January 22, 2025
This study examined 277 GIST patients, finding that systemic steroids used to manage imatinib-induced skin rash did not negatively impact treatment efficacy. There was no significant difference in progression-free survival or overall survival between those using steroids and the control group.
Advertisement
News & Literature Highlights